{
  "trial_id": "NCT02369484",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, ECOG Performance Status, histological subtype, stage of NSCLC, previous treatments, HER2 mutation status, measurable or evaluable disease, haematological function (WBC, haemoglobin, neutrophils count, platelet count), liver function (total bilirubin, ALT, AST, GGT), renal function (creatinine clearance), life expectancy, pregnancy status, contraceptive use, previous therapy-related toxicity, tumour block availability.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "ECOG Performance status",
          "ECOG Performance Status"
        ],
        [
          "TNM staging",
          "stage of NSCLC"
        ],
        [
          "Type of prior platinum treatment",
          "previous treatments"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race and Ethnicity Not Collected",
        "Region of Enrollment",
        "Smoking history",
        "T parameter",
        "N parameter",
        "M parameter"
      ],
      "remaining_candidate_features": [
        "histological subtype",
        "HER2 mutation status",
        "measurable or evaluable disease",
        "haematological function (WBC, haemoglobin, neutrophils count, platelet count)",
        "liver function (total bilirubin, ALT, AST, GGT)",
        "renal function (creatinine clearance)",
        "life expectancy",
        "pregnancy status",
        "contraceptive use",
        "previous therapy-related toxicity",
        "tumour block availability."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Histological Subtype, Previous Platinum-based Chemotherapy, HER2 Mutation Status, White Blood Cell Count, Hemoglobin Level, Neutrophil Count, Platelet Count, Total Bilirubin, ALT, AST, GGT, Creatinine Clearance, Life Expectancy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "ECOG Performance status",
          "ECOG Performance Status"
        ],
        [
          "Type of prior platinum treatment",
          "Previous Platinum-based Chemotherapy"
        ]
      ],
      "remaining_reference_features": [
        "Race and Ethnicity Not Collected",
        "Smoking history",
        "T parameter",
        "N parameter",
        "M parameter",
        "TNM staging"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Histological Subtype",
        "HER2 Mutation Status",
        "White Blood Cell Count",
        "Hemoglobin Level",
        "Neutrophil Count",
        "Platelet Count",
        "Total Bilirubin",
        "ALT",
        "AST",
        "GGT",
        "Creatinine Clearance",
        "Life Expectancy"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Histological Subtype, Number of Previous Chemotherapy Regimens, Best Response to Previous Chemotherapy, Time Since Last Chemotherapy, Presence of Brain Metastases, Presence of Liver Metastases, Presence of Bone Metastases, HER2 Mutation Status, Smoking Status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "ECOG Performance status",
          "ECOG Performance Status"
        ],
        [
          "Type of prior platinum treatment",
          "Number of Previous Chemotherapy Regimens"
        ]
      ],
      "remaining_reference_features": [
        "Race and Ethnicity Not Collected",
        "Smoking history",
        "T parameter",
        "N parameter",
        "M parameter",
        "TNM staging"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Histological Subtype",
        "Best Response to Previous Chemotherapy",
        "Time Since Last Chemotherapy",
        "Presence of Brain Metastases",
        "Presence of Liver Metastases",
        "Presence of Bone Metastases",
        "HER2 Mutation Status",
        "Smoking Status"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, ECOG Performance Status, histological subtype of NSCLC, stage of NSCLC, number of prior chemotherapy regimens, prior platinum-based chemotherapy, presence of brain metastases, presence of liver metastases, presence of other metastases, WBC, haemoglobin, neutrophils count, platelet count, total bilirubin, ALT, AST, GGT, calculated creatinine clearance, HER2 mutation status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "ECOG Performance status",
          "ECOG Performance Status"
        ],
        [
          "TNM staging",
          "stage of NSCLC"
        ],
        [
          "Type of prior platinum treatment",
          "prior platinum-based chemotherapy"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race and Ethnicity Not Collected",
        "Region of Enrollment",
        "Smoking history",
        "T parameter",
        "N parameter",
        "M parameter"
      ],
      "remaining_candidate_features": [
        "histological subtype of NSCLC",
        "number of prior chemotherapy regimens",
        "presence of brain metastases",
        "presence of liver metastases",
        "presence of other metastases",
        "WBC",
        "haemoglobin",
        "neutrophils count",
        "platelet count",
        "total bilirubin",
        "ALT",
        "AST",
        "GGT",
        "calculated creatinine clearance",
        "HER2 mutation status."
      ]
    }
  }
}